Preoperative intravitreal injection of ranibizumab for patients with severe proliferative diabetic retinopathy contributes to a decreased risk of postoperative neovascular glaucoma

Journal article

Open access

Peer reviewed

Qianyi Lu, Chen Zou, Hui Cao, Minjie Zhao, Siqing Yu, Qinghua Qiu, Xun Xu and Zhi Zheng

Acta ophthalmologica (Oxford, England), Vol.94(4), pp.414-415

06/2016

PMID: 27010230

Abstract

Aged

Angiogenesis Inhibitors - therapeutic use

Diabetic Retinopathy - drug therapy

Diabetic Retinopathy - physiopathology

Female

Glaucoma, Neovascular - prevention & control

Humans

Intravitreal Injections

Male

Middle Aged

Postoperative Complications - prevention & control

Ranibizumab - therapeutic use

Retrospective Studies

Vascular Endothelial Growth Factor A - antagonists & inhibitors

Visual Acuity - physiology

Vitrectomy

url

https://doi.org/10.1111/aos.13019View

Published (Version of record) Open

1 Record Views

Title: Preoperative intravitreal injection of ranibizumab for patients with severe proliferative diabetic retinopathy contributes to a decreased risk of postoperative neovascular glaucoma
Creators - without role: Qianyi Lu - Shanghai Jiao Tong University
Chen Zou - Shanghai First People's Hospital
Hui Cao - Shanghai First People's Hospital
Minjie Zhao - Shanghai First People's Hospital
Siqing Yu - Shanghai First People's Hospital
Qinghua Qiu - Shanghai Jiao Tong University
Xun Xu - Shanghai First People's Hospital
Zhi Zheng - Shanghai First People's Hospital
Publication Details: Acta ophthalmologica (Oxford, England), Vol.94(4), pp.414-415
Identifiers: 9945614708331
Academic Unit: King Abdullah University of Science & Technology
Language: English
Resource Type: Journal article